Selective external endarterectomy in patients with ipsilateral symptomatic internal carotid artery occlusion  by Fokkema, Margriet et al.
From the Society for Vascular SurgeryFrom
M
En
Auth
M
Pres
th
Add
Rep
of
N
The
to
m
0741
Cop
httpSelective external endarterectomy in patients with
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Background: Selective endarterectomy of external carotid artery (ECA) stenosis has been considered a therapeutic option
for patients presenting with symptomatic ipsilateral internal carotid artery (ICA) occlusion to correct cerebral hypo-
perfusion or eliminate a source of emboli. However, data are scarce, and the long-term beneﬁt of ECA revascularization
remains unclear. Our objective was to study the operative results and durability of selective ECA endarterectomy in
patients presenting with cerebrovascular symptoms in association with nonacute ipsilateral ICA occlusion.
Methods: This was a retrospective analysis of 27 consecutive patients who underwent selective ECA endarterectomy in
a single center between 2000 and 2010. All patients presented with neurologic symptoms (<6 months of surgery, 78%
repeat events) referable to an ipsilateral occlusion of the ICA and concomitant stenosis of the ECA. We assessed the
perioperative clinical outcome <30 days and at midterm follow-up (mean, 31.6 months). Patency was deﬁned as freedom
of duplex ultrasound detected $50% restenosis.
Results: Endarterectomy of the ECA was successful in 26 patients (96.3%) with one ECA found occluded at surgery. No
perioperative deaths occurred. In the 30 days after surgery, one patient developed an ipsilateral disabling ischemic stroke
(3.7%), and one patient (3.7%) had a myocardial infarction. At follow-up, nine patients had died: one of a fatal ischemic
stroke, six of non-vascular-related causes, and two of unknown causes. At 3 years, 83% (standard error, 8%) of patients
were free from stroke or death, and 80% (standard error, 8%) of the operated-on arteries were patent. Five patients
developed restenosis $50% (n [ 2, asymptomatic) or occlusion (n [ 3, one symptomatic) #3 months, and two other
patients developed late asymptomatic restenosis.
Conclusions: Selective endarterectomy of the ECA in symptomatic patients with an ipsilateral occlusion of the ICA is
a feasible procedure with an acceptable perioperative risk. Most patients remain stroke-free during follow-up and have
a low rate of symptomatic restenosis. (J Vasc Surg 2013;58:145-51.)Focal brain region perfusion in patients with symptom- patients with symptomatic occlusion and proven compro-
atic internal carotid artery (ICA) occlusion depends on the
contribution from collateral arteries.1 In many patients, the
ipsilateral external carotid artery (ECA) may form an
important collateral route, mainly through the ophthalmic
artery. If the ECA contains a ﬂow-limiting high-grade
stenosis, revascularization through endarterectomy of this
artery may improve cerebral blood ﬂow or eliminate
a possible embolic source.2,3 The recent Carotid Occlusion
Surgery Study randomized trial showed no beneﬁt in stroke
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://dx.doi.org/10.1016/j.jvs.2012.12.059mised cerebral perfusion compared with the control group
receiving best medical treatment.4 Therefore, alternative
treatments for patients with symptomatic ICA occlusion
are regaining interest and need to be evaluated.
Few patients undergo selective endarterectomy of the
ECA, and evidence on the beneﬁt of any revascularization
in patients with symptomatic ICA occlusion is still debated
in the current literature. Most data on revascularization of
the ECA come from observational studies based on small
case series with heterogeneous patient selection.5-21
However, most of these studies also included extended
procedures such as carotid-subclavian bypass or EC-IC
bypass surgery. At present, data on outcomes of purely
and selective ipsilateral ECA endarterectomy for patients
presenting with a symptomatic ICA occlusion are still
limited, and the long-term beneﬁt of selective ECA endar-
terectomy remains unclear. Therefore, we evaluated all
patients within a large tertiary vascular surgery referral
center with symptomatic nonacute ICA occlusion who
underwent selective ipsilateral ECA endarterectomy and
analyzed perioperative and long-term outcome.
METHODS
Clinical work-up. We used our prospective database
on all carotid artery revascularization procedures to search145
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tion of the ECA between September 2000 and August
2010 in the University Medical Center Utrecht. Patients
were eligible if (1) they were scheduled for selective ipsilat-
eral endarterectomy of the ECA (extended to the common
carotid artery if necessary), (2) no adjunctive procedures
were performed, (3) symptoms were ipsilateral to a non-
acute ICA occlusion, (4) procedural details and 30-day
outcomes were reported, and (5) follow-up data were
available for at least 3 months. The indication for endar-
terectomy of the ECA was discussed in all patients at
a weekly 1- to 2-hour multidisciplinary conference with
neurologists, radiologists, and vascular surgeons as part of
routine clinical practice.
Data collection and follow-up. Patient characteristics
and outcomes data were retrieved from electronic medical
records. The general practitioner was contacted if there
were any uncertainties or if additional information was
required (eg, cause of death during follow-up). Imaging
data were obtained from our vascular laboratory. Symp-
toms during regular follow-up were objectiﬁed in the
outpatient clinic by an experienced independent vascular
neurologist (C.K.). Patients with missing imaging data or
follow-up of <2 years were contacted to undergo an
additional duplex ultrasound (DUS) imaging and
a consultation at the neurologist’s outpatient clinic.
Surgical techniques. All patients underwent surgery
under general anesthesia. As a standard of practice in our
clinic, cerebral function and perfusion were monitored
with electroencephalography and transcranial Doppler
during surgery. Findings were used in the same way as
with conventional endarterectomy of the ICA. A decrease
of <50% of baseline velocity in the ipsilateral middle cere-
bral artery on transcranial Doppler might lead to shunting
as well as focal ipsilateral or bilateral decreases in ampli-
tudes and slowing of electroencephalography waves. The
ﬁnal decision on whether to place a shunt was left to the
discretion of the operating surgeon.
A board-certiﬁed vascular surgeon performed selective
endarterectomy of the ECA using the same standardized
approach as for longitudinal carotid endarterectomy. The
arteriotomy was carried from the CCA into the ECA
beyond the distal extent of the stenosis. A standard endar-
terectomy plane was created and revascularization per-
formed. The oriﬁce of the ICA was oversewn in all cases
using 5-0 Prolene suture (Ethicon, Somerville, NJ) to
prevent cul-de-sac emboli. In case of persisting irregularities
on the ICA origin, additional ICA ligation was performed.
A patch angioplasty, consisting of autologous vein,
Dacron (DuPont, Wilmington, Del), or bovine pericar-
dium, was applied at the discretion of the operating
surgeon. Autologous vein patches were harvested from
the distal great saphenous vein at the ankle. Standard post-
operative medical management was applied and consisted
of antiplatelet drugs combined with a statin.
Patients. Eight of the 35 patients initially considered
for inclusion were excluded because procedures other
than surgical ECA endarterectomy were performed,including one stent placement and one EC-IC bypass,
ﬁve concomitant ipsilateral or contralateral procedures, and
one ECA revascularization on the side of a nonoccluded
ICA (>70% stenosis). The study included the remaining 27
patients, and their baseline characteristics are summarized
in Table I. Patients were a mean age of 64.3 years (range,
48-79 years), and 19 (70.4%) were men.
DUS degree of ECA stenosis $50% was conﬁrmed by
a second imaging modality (magnetic resonance angiog-
raphy or computed tomography angiography). All patients
had preoperative neurologic symptoms referable to a non-
acute ipsilateral ICA occlusion. The mean time from ICA
occlusion (proven on imaging studies) to surgery was 8
months (range, 0.8-37 months). Presenting symptoms
included ischemic stroke in four (14.8%), hemispheric tran-
sient ischemic attack (TIA) in seven (25.9%), or any ocular
symptoms in 13 (48.1%), consisting of amaurosis fugax in
11 and the syndrome of chronic ocular ischemia (SCOI,
eg, blurred vision and progressive visual loss22) in 3; in one
patient, both were present. Three patients (11.1%) pre-
sented with ocular symptoms and hemispheric TIAs. All
symptoms were present #6 months before surgery, and 21
patients (77.8%) experienced recurrent events. Six patients
underwent ECA surgery because of a single neurologic
event in combination with severe cerebrovascular athero-
sclerosis. The exact indication for ECA endarterectomy is
outlined in the Supplementary Table (online only). Bilateral
ICA occlusion was present in ﬁve patients (18.5%).
End points. The primary end point was the develop-
ment from any major cardiovascular adverse event,
including stroke, myocardial infarction (MI), or death.
The secondary end point was deﬁned as freedom of pre-
senting symptoms, without the development of any new
minor neurologic symptoms (hemispheric TIAs or ocular
symptoms, or both). The tertiary end point was patency
of the treated ECA. Restenosis was deﬁned as $50%
stenosis by DUS criteria23 (mean peak systolic velocity
of the ECA $150 cm/s) or as $50% stenosis on duplex
subtraction angiography, computed tomography angiog-
raphy, or magnetic resonance angiography. Occlusion was
deﬁned as a 100% stenosis without blood ﬂow. Lastly,
immediate technical success and procedure-related local
events, such as infection, bleeding needing reintervention,
and permanent or transient cranial nerve injury (CNI) were
assessed postoperatively by the operating surgeon. Results
were analyzed during the perioperative period (<30 days)
and at follow-up at 3 months and thereafter. Survival
analyses were performed to demonstrate patency and
freedom from stroke or death over time using SPSS 19.0
software (SPSS Inc, Chicago, Ill).
RESULTS
Perioperative outcome. The operation was technically
successful in 26 patients (96.0%). Revascularization could
not be performed in one patient because the ECA was oc-
cluded at the timeof surgery.Nopatients died.One ipsilateral
disabling ischemic stroke (3.7%) occurred 1 day after surgery,
most likely caused by hypotension, without occlusion of
Table II. Perioperative outcome (<30 days) for 27
patients
Outcome No. (%)
Major outcome
Death 0 (0)
Strokea 1 (3.7)
Myocardial infarction 1 (3.7)
Procedure-related local events
Wound infection 0 (0)
Bleeding 1 (3.7)
Cranial nerve injury 2 (7.4)
Technical success 26 (96.0)
Patch usedb 18 (66.7)
Shunt used 1 (3.7)
ICA ligation 7 (25.9)
ICA, Internal carotid artery.
aIpsilateral, ischemic.
b16 venous, 1 Dacron, 1 bovine.
Table I. Characteristics and preoperative risk factors of 27
patients who underwent external carotid endarterectomy
Patient characteristics
Median (range)
or No. (%)
Age, yearsa 64.3 (48-79)
Male sex 19 (70.4)
Presenting symptomsb
Ischemic stroke 4 (14.8)
Hemispheric TIA 7 (25.9)
Ocular symptoms (AFX and/or SCOI) 13 (48.1)
Hemispheric TIA and ocular symptoms 3 (11.1)
Time from ICA occlusion to surgery, monthsa 8 (0.8-37)
Right side treated 16 (59.3)
Contralateral ICA occlusion 5 (18.5)
Risk factors
Current smoker 12 (44.4)
Hypertension 15 (55.6)
Hypercholesterolemia 22 (81.5)
Diabetes mellitus 3 (11.1)
Coronary artery disease 10 (37.0)
Peripheral artery disease 9 (33.3)
GFR, mL/min/1.73 m2 65.5 (31.7-109.2)
Body mass index, kg/m2 27.2 (23.6-38.0)
AFX, Amaurosis fugax; GFR, glomerular ﬁltration rate; ICA, internal
carotid artery; SCOI, syndrome of chronic ocular ischemia; TIA, transient
ischemic attack.
aData presented as mean (range).
bAll symptoms ipsilateral of side of ICA occlusion.
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MI occurred in another patient (3.7%). Procedure-related
local events included transient CNI (hypoglossal nerve) in
two patients (7.4%) and bleeding needing re-exploration
in one (3.7%; Table II). In seven patients (25.9%), the
origin of the occluded ICA was ligated (ICA oriﬁce left
in place) during the surgical procedure. A shunt was
used preventively in one operation because of bilateral
occlusion. The arteriotomy was closed with a patch angio-
plasty in 18 patients (66.7%), with an ICA transposition
ﬂap in two (7.4%), and was closed primarily in seven patients
(25.9%).Outcome at 3 months. No new strokes, MIs, or
deaths were noted at 3 months, but three patients had
minor neurologic symptoms. In one patient who experi-
enced amaurosis and jaw claudication, the ECA proved
to be occluded on DUS imaging. Two other patients had
recurrent ipsilateral amaurosis (n ¼ 1) and ipsilateral limb
shaking TIAs (n ¼ 1). Relief of symptoms was obtained
after starting dual-antiplatelet treatment (aspirin combined
with clopidogrel) in the ﬁrst patient and after endarterec-
tomy of the contralateral ECA in the second patient. The
cumulative patency rate after 3 months was 80% (standard
error [SE], 8%; n ¼ 22; Fig 1). A restenosis $50% was seen
in two patients (arteries closed with a patch), and the ECA
appeared to be occluded in three other patients (two
arteries closed primarily, one with patch). One of these
occlusions (3.7%; patient described above) became
symptomatic.
Midterm outcome. The mean follow-up was 31.6
months (range, 3-78 months). Four patients were lost
to follow-up after 3 months. Of these, two patients died,
apparently of nonvascular causes, without follow-up >3
months, and one patient refused further follow-up consul-
tation. The patient whose operation failed remained
symptom-free and was therefore not further consulted after
3 months. Nine patients died during the course of follow-up;
six patients died of nonvascular causes and the cause of death
in two patients was unknown (both patients completed
follow-up >3 years and were symptom-free). One patient
sustained a fatal stroke (territory unknown) after 18 months
of follow-up. This patient was known to have severe bilateral
disease in both carotid and vertebral arteries, although the
treated ECA stayed patent without restenosis (peak systolic
velocity, 60 cm/s). At 3 years, 83% (SE, 8%) of patients were
free from stroke or death (Fig 2). Three patients had minor
neurologic symptoms. One patient had hemispheric TIAs
and amaurosis fugax at 20 months; however, the frequency
of TIAs decreased, and no progression of ocular symptoms
was encountered after stenting of the ipsilateral vertebral
artery to optimize cerebral blood ﬂow. The second patient
had hemispheric TIAs at 43 months of follow-up. The third
patient had recurrent ipsilateral amaurosis fugax at 9 months
of follow-up. In this patient, a $50% restenosis of the ECA
had already been found at 3 months, but symptoms became
apparent at 9 months. Two other new asymptomatic reste-
noses were identiﬁed (arteries closed primarily). At 3 years,
80% (SE, 8%) of arteries were patent (Fig 1).
DISCUSSION
On the basis of our single-center experience, ECA
revascularization through endarterectomy proved to be
a feasible procedure with low perioperative morbidity and
mortality. Clinical results yielded one early nonfatal stroke
and one late fatal stroke. Although three patients experi-
enced early minor neurologic symptoms and three other
patients developed late minor symptoms, most patients
were relieved from their initial presenting symptoms.
Patency at 3 months and 3 years was 80%. The results of
this study indicate that external carotid endarterectomy
Fig 1. Survival analysis shows cumulative proportion of 27 patients with freedom from restenosis or occlusion after
undergoing external carotid endarterectomy. SE, Standard error.
Fig 2. Survival analysis shows cumulative proportion of 27 patients with freedom from nonfatal stroke or death after
undergoing external carotid endarterectomy. SE, Standard error.
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Table III. Overview of the literature on ECA revascularization; outcome per studya
Study author,
year No.b
Age, mean
years
ECA
revascularization
30-day
stroke/death
FU, mean
years
Relieve/
improve
of Sx, %
Stroke/death/
vascular death
Restenosis (Sx)/
occlusion (Sx)sECA Other
UMCU, 2012 27 65 27 0 1/0 3 87 1/9/1c 4(0)/1(1)
Paty,5 2003 57 66 57d 0 0/1 1.8 NA 0/6/4 0(0)/2(0)
Karkos,6 2000 8 64 5 3 0/0 3.4 100 0/1/1 0(0)/0(0)
AbuRahma,7 1998e 13 61 8 5 0/0 6 100 1/5/5 NA
Harris,8 1995 7 66 8f 0 0/0 3.3 85.7 0/0/0 1(1)/0(0)
Rush,9 1992 19 60 2f 0 0/0 3.4 63.2 3/6/5 3(NA)/1(NA)
Boontje,10 1992 11 (50-79) 11g 0 0/0 4.5 100 2/5/0 NA
Nicholls,21 1989 4 NA 4 0 0/0 NA 100 1/1/1 NA
Floriani,11 1989 6h 62 6d 0 0/0 1.9 83.3 0/1/1 0(0)/0(0)
Sterpetti,12 1988 22 61 25f 0 1/0 3 65 1/NA/NA 8(4)/1(1)i
Friedman,13 1988 22 61 20d 7d 0/0 3.8 89.5 0/3/2 NA
Nicolosi,14 1988 11 63 11d 0 0/0 2.5 73 0/5/1c NA
Belkin,15 1988 5 64 6 0 0/0 NA 80 0/0/0 NA
Santiani,16 1987 15j 61 14d 1 0/0 2.2 73.3 2/2/2 NA
Gertler,17 1987k 218 62 195 23 2/7 NA 90l 7/NA/8m NA
Street,18 1987n 16 65 15 1 0/0 1.5 63 0/0/0 NA/(NA)/1(1)
Fisher,19 1986n 13o 60 11 3 0/0 1.8 86 0/0/0 2(2)/0(0)
Rogers,20 1982n 14 NA 14d 0 0/0 NA NA 0/0/0 NA
ECA, External carotid artery; FU, follow-up; ICA, internal carotid artery; NA, not available; sECA, selective external carotid artery endarterectomy, unless
otherwise indicated; Sx, symptoms; TIA, transient ischemic attack.
3 and 5 and 1 subclavian or common carotid artery-ECA bypass, results not included in outcome.
aData reported as number of patients unless indicated otherwise.
bAll patients presenting symptomatic with ipsilateral ICA occlusion, unless otherwise indicated.
cTwo unknown causes of death.
dSome patients had adjunctive bypasses (n ¼ 3, 3, 6, 1, 2, and 9, respectively).
eAll patients had bilateral occlusion.
fBilateral procedure (n ¼ 1, 2, and 3, respectively).
gThree patients underwent cul-de-sac removal alone, without ECA endarterectomy.
hFour of six patients had a 100% ICA stenoses.
iData available for 16 patients.
jOne patient had contralateral TIA.
kCollective review of 23 articles.
lOutcome not speciﬁed for 19%.
mData available for 196 patients.
nArticles published <1978 not included in article by Gertler et al.
oTwo asymptomatic patients.
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who most often present with repeat symptoms referable
to a nonacute ICA occlusion and severe external carotid
stenosis. However, the net beneﬁt will be limited in
patients with poor life expectancy and severe generalized
cardiovascular disease.
Symptomatic ICA occlusion has a signiﬁcant annual risk
of stroke of 2.4% to 6%, with the highest risk in the ﬁrst 1.5
years after presentation (8%).24-26 Occlusion of the ICA may
result in a hemodynamic stroke, a type of ischemic stroke
that is caused by hypoperfusion rather than by embolism
or local vasculopathy.27 Neurologic symptoms may arise if
the collateral pathways (via the contralateral intracranial
ﬂow via the circle of Willis, the ipsilateral ECA, or the poste-
rior circulation) are diminished.28 Optimization of cerebral
blood ﬂow can be considered to relieve cerebrovascular
symptoms and to prevent stroke and subsequent death.29
Few treatment options are available for these patients,
with secondary preventive medication being the standardof care. Currently, no type of revascularization has been
shown of proven beneﬁt.2,4
Earlier cohort studies, most of which were published
before 1990, showed the 30-day safety of endarterectomy
of the ECA in patients with established ipsilateral ICA occlu-
sion. In a literature review that included most series pub-
lished before 1987, 195 ECA endarterectomies and 23
ECA bypasses were described in symptomatic patients with
ipsilateral ICA occlusion.17 The overall 30-day neurologic
complication rate was 5%, and the perioperative mortality
rate was 3%. Many patients in these series received ECA
surgery preceding EC-IC bypass surgery or combined with
adjunctive carotid-subclavian surgery, and would thus be
exposed to higher operative risk than those undergoing
ECA endarterectomy alone.30 A subsequent literature over-
view 1 year later of 192 selective ECA endarterectomy
procedures reported that selective ECA endarterectomy
alone carried a low risk, with a perioperative neurologic
deﬁcit rate of 1.6% and a mortality rate of 0%.12
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ECA endarterectomy were published. The most recent
and largest single-center series involved 57 patients.5
Although three patients had adjunctive bypasses and the
eversion technique was used in 73%, the results were com-
parable to our study. The 30-day complications included
one death, one MI, one neck hematoma, and one asymp-
tomatic occlusion. At 3 years, stroke-free survival was 86%
(SE, 7.8%), which was consistent with the 83% (SE, 8%)
in the current series. An updated summary of the available
literature is reported in Table III. Although these studies
were not generalizable, the overall complication risk with
ECA surgery was acceptably low and seems to outweigh
the annual stroke risk as identiﬁed in patients with ICA
occlusion without revascularization.
Despite 50 years of experience with extracranial surgical
techniques, the exact indications and outcome of selective
ECA endarterectomy remain poorly deﬁned.6 There seems
to be no role for ECA revascularization in asymptomatic
patients with ICA occlusion or in patients presenting with
a major stroke at time of occlusion of the ICA without
further neurologic or ocular symptoms.2,7 In patients
without recurrent symptoms and major stroke, sufﬁcient
collateral pathways are expected to compensate for the
absent ipsilateral ICA ﬂow. None of the four patients in
our cohort who presented with a single stroke experienced
further neurologic events, despite occlusion or restenosis in
two of these.
Currently, advanced imaging techniques, such as selec-
tive arterial spin-labeled MRI, are available to aid patient
selection. Selective arterial spin-labeled perfusion MRI
was recently introduced as a method to assess the contribu-
tion of the individual arteries to the perfusion of the
brain.31 If the brain region supplied by the ECA contains
diminished ﬂow, ECA endarterectomy is more likely to
provide beneﬁt.1 Although we were not able to use these
new imaging techniques, they might be of help to select
future patients who will beneﬁt most from surgical inter-
vention and to objectively determine the change in cerebral
perfusion after intervention.
Surgical techniques for ECA endarterectomy have been
widely discussed in the literature.11,12,19 ECA endarterec-
tomy seems neither more risky nor more technically
demanding than ICA endarterectomy.9 Patch (venous or
prosthetic) closure or closure with a part of the ICA and
obliteration of the ICA stump was associated with improved
patency outcome in other series.9,12 Nine of the arteries in
our series were closed primarily, most likely because the
ECA had a sufﬁciently large lumen. Our numbers were
too small to relate method of closure with patency at
follow-up. Although patch ruptures have been reported
as a complication, none was seen in patients with venous
patches obtained from the ankle.
Patients with bilateral ICA occlusion seem to have
a comparable risk for subsequent ischemic stroke as patients
with unilateral occlusion.32 The risk of surgery in patients
with bilateral occlusion is expected to be higher, but endar-
terectomy of the ECA has demonstrated low operative riskand resulted in increased cerebral perfusion and relief of
symptoms.7,17 Four of ﬁve patients in our cohort with bilat-
eral occlusion did clinically well, and three of the ﬁve ECAs
stayed patent during follow-up. Also in patients with bilat-
eral occlusion, compensation through collateral branches
other than the ECA have likely developed over time to
supply adequate ﬂow and prevent further symptoms.
This study was limited by the use of retrospective data
and the low incidence of selective ECA endarterectomy in
a highly selected population. For example, we were not
able to differentiate patients who were operated on for
a hemodynamic problem from patients who were treated
to eliminate a source of emboli because preoperative
studies investigating ﬂow could not be obtained. Also,
the reasons for some technical decisions during surgery,
such as patch and shunt use, could not be determined.
However, detailed information on follow-up data was avail-
able, and the long-term clinical effect of this rare surgery
could be carefully analyzed.
CONCLUSIONS
For patients with nonacute symptomatic ICA occlusion
and symptoms referable to a low-ﬂow state or embolic
events due to ECA stenosis, selective ECA endarterectomy
seems a feasible and durable treatment with low operative
risk and offering freedom from major neurologic symptoms
during follow-up.
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Supplementary Table (online only). Patients with
a single event after or during an ipsilateral internal carotid
artery occlusion as their indication for surgery
No. Single event
Time from ICA
occlusion to
surgery Reasons for surgery
1 Stroke 1 month String sign contralateral
ICA, ECA stenosis
(>80%)
2 Amaurosis fugax 2 months Severe four-vessel disease
3 Stroke 3 weeks High-grade contralateral
ICA stenosis (80%-99%)
and severe bilateral ECA
stenosis (>70%)
4 Stroke 6 months Bilateral ICA occlusion and
severe bilateral ECA
stenosis (>70%)
5 Stroke 5 months Severe four-vessel disease
6 Ocular ischemic
syndrome with
blindness
9 months Bilateral ICA occlusion and
young age; ECA stenosis
(>80%)
ECA, External carotid artery; ICA, internal carotid artery.
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